Diagnostisk præstation af præoperativ [ 18 F] FDG-PET / CT til lymfeknudestaging i vulvarcancer: en stor single-center-undersøgelse
Function: This retrospective research aimed to evaluate the diagnostic efficiency of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) standing in a big single-centre collection of vulvar most cancers sufferers.
Strategies: Between January 2013 and October 2018, amongst all consecutive ladies with confirmed vulvar most cancers submitted to [18F]FDG-PET/CT, 160 sufferers had been included. LNs had been analysed by two qualitative strategies assessing PET info (outlined as visible evaluation) and a mix of PET and low-dose CT info (outlined as total evaluation), respectively, in addition to semi-quantitative evaluation (LN-SUVmax).
Sensitivity, specificity, accuracy, constructive and detrimental predictive values (PPV and NPV) in predicting the groin and pelvic LN standing had been calculated within the total research inhabitants; a subset evaluation of groin parameters in clinically/ultrasonography detrimental sufferers was additionally carried out. Histopathology was the reference customary.
Outcomes: All sufferers underwent vulvar and inguinofemoral LN surgical procedure, and 35 pelvic LN surgical procedure. General, 338 LN websites (296 groins and 42 pelvic websites) had been histologically examined with 30.4% prevalence of metastatic groins and 28.6% for metastatic pelvic websites.
Within the total research inhabitants, sensitivity (95% confidence interval, CI), specificity (95% CI), accuracy (95% CI), PPV (95% CI) and NPV (95% CI) on the groin degree had been 85.6% (78.3-92.8), 65.5% (59.0-72.0), 71.6% (66.5-76.8), 52.0% (44.0-60.1) and 91.2% (86.7-95.8) for visible evaluation; 78.9% (70.5-87.3), 78.2% (72.5-83.8), 78.4% (73.7-83.1), 61.2% (52.3-70.1) and 89.4% (85.0-93.9) for total evaluation; and 73.3% (64.2-82.5), 85.0% (80.1-89.8), 81.4% (77.0-85.8), 68.0% (58.8-77.3) and 87.9% (83.4-92.5) for semi-quantitative evaluation (SUVmax cut-off worth 1.89 achieved by ROC evaluation). Comparable outcomes had been noticed within the pelvis-based evaluation.
Conclusion: On this giant single-centre collection of vulvar most cancers sufferers, [18F]FDG-PET/CT confirmed good values of sensitivity and NPV in discriminating metastatic from non-metastatic LNs. In routine medical observe, qualitative evaluation is a dependable interpretative criterion making pointless generally used semi-quantitative strategies resembling SUVmax.
Key phrases: Lymph node staging; Customized medication; Vulvar most cancers; [18F]FDG-PET/CT.
Anti-PLA2R og anti-THSD7A som diagnostiske serologiske markører for idiopatisk membranøs nefropati: En enkelt centerundersøgelse
Idiopathic Membranous Nephropathy (IMN) is a renal-limited autoimmune illness and accounts for roughly 80% of MNs. This research aimed to guage the position of circulating Anti-PLA2R and anti-THSD7A autoantibodies within the analysis and differentiation between main and secondary MN. This research was performed on 58 grownup sufferers with biopsy-proven membranous glomerulopathy (MGN).
All had been subjected to measurement of Anti-PLA2R1 by an Enzyme-Linked Immunosorbent Assay and anti-THSD7A was detected by an oblique immunofluorescence assay. Among the many 58 sufferers, 79.3% had been identified as IMN, and 20.7% as secondary membranous glomerulopathy (SMN).
Amongst IMN sufferers, 32 sufferers (69.6%) confirmed constructive anti-PLA2R1 antibodies, 2 sufferers (4.3%) had been constructive for anti-THSD7A antibodies and the remaining 12 sufferers (26.1%) had been detrimental for each kinds of antibodies. Sufferers with SMN had been detrimental for the 2 antibodies.
The IMN sufferers had decrease serum creatinine in comparison with the SMN sufferers (P=0.017). In conclusion, the research demonstrates that roughly 70% of sufferers with idiopathic membranous nephropathy have antibodies in opposition to PLA2R indicating that Anti-PLA2R could also be quick, simple, comparatively delicate, and non-invasive check for analysis of IMN.

![]() ALT. THIOGLYCOLLATE MED. |
|||
A01-103-2Kg | Alphabiosciences | 2 Kg | Ask for price |
![]() ALT. THIOGLYCOLLATE MED. |
|||
A01-103-500g | Alphabiosciences | 500 g | Ask for price |
![]() Bouin's Fluid |
|||
BNF125 | ScyTek Laboratories | 125 ml | EUR 63 |
![]() Bouin's Fluid |
|||
BNF3800 | ScyTek Laboratories | 1 Gal. | EUR 178 |
![]() Bouin's Fluid |
|||
BNF500 | ScyTek Laboratories | 500 ml | EUR 80 |
![]() Bouin's Fluid |
|||
BNF999 | ScyTek Laboratories | 1000 ml | EUR 98 |
![]() P-Selectin (PF377), RNA Aptamer, unlabeled |
|||
AR-298-U | Alpha Diagnostics | Custom | Ask for price |
![]() Rat Neuromedin U control/blocking peptide # 2 |
|||
NMU51-P | Alpha Diagnostics | 100 ug | EUR 164 |
![]() Human Neuromedin U control/blocking peptide # 3 |
|||
NMU61-P | Alpha Diagnostics | 100 ug | EUR 164 |
![]() Mouse Neuromedin U control/blocking peptide # 4 |
|||
NMU71-P | Alpha Diagnostics | 100 ug | EUR 164 |
![]() Michel's Transport Fluid |
|||
MTF-10000 | ScyTek Laboratories | 10 L | EUR 762 |
![]() Michel's Transport Fluid |
|||
MTF-20000 | ScyTek Laboratories | 20 L | EUR 1340 |
![]() Michel's Transport Fluid |
|||
MTF500 | ScyTek Laboratories | 500 ml | EUR 98 |
![]() Michel's Transport Fluid |
|||
MTF999 | ScyTek Laboratories | 1000 ml | EUR 127 |
![]() Ansamitocin P-3 |
|||
ADC-P-003 | Creative Biolabs | unit | Ask for price |
![]() Neuromedin U (R/M/H) control/blocking peptides |
|||
NMU41-P | Alpha Diagnostics | 100 ug | EUR 164 |
![]() AXYPREP MAG PLASMID KIT- MEDIUM - 384 PREPS |
|||
MAG-P-M | CORNING | 1/pk | EUR 664 |
Description: Bioscience Mag Beads; Magnetic Plasmid |
![]() HE4, Human ascites fluid |
|||
P1438-100 | Biovision | EUR 620 |
![]() HE4, Human ascites fluid |
|||
P1438-500 | Biovision | EUR 2839 |
![]() SOF Synthetic Oviduct Fluid. |
|||
IVL05-100ML | Caisson Labs | 100 ml | EUR 78 |
Description: Synthetic Oviduct Fluid. |
![]() SOF Synthetic Oviduct Fluid. |
|||
IVL05-6X100ML | Caisson Labs | 6 x 100 ml | EUR 151 |
Description: Synthetic Oviduct Fluid. |
![]() 96-Well, pureGrade, Clear Transparent, U-Bottom, 5 Plates/Sleeve, 100/Unit |
|||
33-572X | Genesee Scientific | 100 plates | EUR 240 |
Description:
|
![]() Transparent, 96-Well Plates, pureGrade Sterile, Clear U-Bottom 50 Plates/Unit |
|||
91-420U | Genesee Scientific | 50 plates | EUR 230 |
Description:
|
![]() Calci-Clear |
|||
NAT1312 | National Diagnostics | EACH | EUR 78 |
![]() Calci-Clear |
|||
NAT1314 | National Diagnostics | EACH | EUR 128 |
![]() Calci-Clear |
|||
NAT1316 | National Diagnostics | EACH | EUR 386 |
![]() Histo-Clear |
|||
NAT1330 | National Diagnostics | 1 US gallon | EUR 154 |
![]() Histo-Clear |
|||
NAT1332 | National Diagnostics | 5 US gallons | EUR 583 |
![]() Hepatitis B Virus (HBV) Polymerase (P protein) (A9), RNA Aptamer, unlabeled |
|||
AR-233-U | Alpha Diagnostics | Custom | Ask for price |
![]() Mouse p/CIP/p300 Control/blocking peptide # 1 |
|||
CIP11-P | Alpha Diagnostics | 100 ug | EUR 164 |
![]() Mouse p/CIP/p300 Control/blocking peptide # 2 |
|||
CIP12-P | Alpha Diagnostics | 100 ug | EUR 164 |
![]() YLKKIKNSL, P. falciparum circumsporozoite (CSP 334-342) polypeptide |
|||
CSPF15-P | Alpha Diagnostics | 1 mg | EUR 286 |
![]() MICROPLATE, 96 WELL, POLYSTYRENE, CLEAR, ROUND BOTTOM, MEDIUM BINDING, NO LID, NONSTERILE, BULK |
|||
3797 | CORNING | 25/pk | EUR 179 |
Description: Assay; EIA/RIA - 96 Well |
![]() CA-125, Human Ascites Fluid |
|||
P1446-10 | Biovision | EUR 294 |
![]() Human Substance P Peptide (amide salt) |
|||
SP15-P-1 | Alpha Diagnostics | 1 mg | EUR 164 |
![]() Human Substance P Peptide (amide salt) |
|||
SP15-P-25 | Alpha Diagnostics | 25 mg | EUR 529 |
![]() Human Substance P Peptide (amide salt) |
|||
SP15-P-5 | Alpha Diagnostics | 5 mg | EUR 286 |
![]() LEYYLREKAKMAGTLIIPES, P. vivax PvMSP-1 peptide 19 (378-397) |
|||
MSPV11-P | Alpha Diagnostics | 1 mg | EUR 164 |
![]() SKDQIKKLTSLKNKLERRQN, P. vivax PvMSP-1 peptide 53 (1058-1077) |
|||
MSPV12-P | Alpha Diagnostics | 1 mg | EUR 164 |
![]() NFVGKFLELQIPGHTDLLHL, P. vivax PvMSP-1 peptide 4 (78-97) |
|||
MSPV13-P | Alpha Diagnostics | 1 mg | EUR 164 |
![]() FNQLMHVINFHYDLLRANVH, P. vivax PvMSP-1 peptide 6 (118-137) |
|||
MSPV14-P | Alpha Diagnostics | 1 mg | EUR 164 |
![]() LDMLKKVVLGLWKPLDNIKD, P. vivax PvMSP-1 peptide 8 (158-177) |
|||
MSPV15-P | Alpha Diagnostics | 1 mg | EUR 164 |
![]() U-104 |
|||
9631-25 | Biovision | EUR 414 |
![]() U-104 |
|||
9631-5 | Biovision | EUR 142 |
![]() U-18666A |
|||
9469-100 | Biovision | Ask for price |
![]() U-18666A |
|||
9469-25 | Biovision | EUR 457 |
![]() U-18666A |
|||
9469-5 | Biovision | EUR 153 |
![]() Kazinol U |
|||
TBW00590 | ChemNorm | unit | Ask for price |
![]() Gomisin U |
|||
TBW01615 | ChemNorm | 5mg | Ask for price |
![]() Ixerin U |
|||
TBZ1502 | ChemNorm | unit | Ask for price |
![]() U-93631 |
|||
B1851-25 | Biovision | EUR 544 |
![]() U-93631 |
|||
B1851-5 | Biovision | EUR 175 |
![]() U-73122 |
|||
B1887-25 | Biovision | EUR 544 |
![]() U-73122 |
|||
B1887-5 | Biovision | EUR 175 |
![]() U-73343 |
|||
B1888-5 | Biovision | EUR 175 |
![]() U-74389G |
|||
20-abx076631 | Abbexa |
|
|
![]() U-0126 |
|||
20-abx076796 | Abbexa |
|
|
![]() U-101017 |
|||
HY-19250 | MedChemExpress | 1mg | EUR 1125 |
![]() U-73343 |
|||
HY-108630 | MedChemExpress | 5mg | EUR 234 |
![]() U-73122 |
|||
HY-13419 | MedChemExpress | 10mM/1mL | EUR 147 |
![]() U-104 |
|||
HY-13513 | MedChemExpress | 10mM/1mL | EUR 113 |
![]() U 0126 |
|||
E1B1901 | EnoGene | 1mg | EUR 161 |
![]() U-44069 |
|||
C5324-1 | ApexBio | 1 mg | EUR 224 |
Description: EC50: 3 ?M and 54 nM for platelet aggregation and phosphatidate formation in human platelets, respectivelyU-44069 is a TP receptor agonist. |
![]() U-44069 |
|||
C5324-10 | ApexBio | 10 mg | EUR 1442 |
Description: EC50: 3 ?M and 54 nM for platelet aggregation and phosphatidate formation in human platelets, respectivelyU-44069 is a TP receptor agonist. |
![]() U-44069 |
|||
C5324-5 | ApexBio | 5 mg | EUR 833 |
Description: EC50: 3 ?M and 54 nM for platelet aggregation and phosphatidate formation in human platelets, respectivelyU-44069 is a TP receptor agonist. |
![]() U 90042 |
|||
B7164-10 | ApexBio | 10 mg | EUR 350 |
![]() U 90042 |
|||
B7164-50 | ApexBio | 50 mg | EUR 1266 |
![]() U 89843A |
|||
B7165-10 | ApexBio | 10 mg | EUR 292 |
![]() U 89843A |
|||
B7165-50 | ApexBio | 50 mg | EUR 1054 |
![]() U 93631 |
|||
B7170-10 | ApexBio | 10 mg | EUR 248 |
![]() U 93631 |
|||
B7170-100 | ApexBio | 100 mg | EUR 1407 |
![]() U 93631 |
|||
B7170-5 | ApexBio | 5 mg | EUR 195 |
![]() U 93631 |
|||
B7170-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 209 |
![]() U 93631 |
|||
B7170-50 | ApexBio | 50 mg | EUR 864 |
![]() U 73343 |
|||
B9013-10 | ApexBio | 10 mg | EUR 224 |
![]() U 73343 |
|||
B9013-25 | ApexBio | 25 mg | EUR 441 |
![]() U 73343 |
|||
B9013-5 | ApexBio | 5 mg | EUR 154 |
![]() U-104 |
|||
A4358-10 | ApexBio | 10 mg | EUR 108 |
Description: U-104 is a novel ureido-sulfonamide inhibitor of Carbonic Anhydrase IX (CAIX). Tumor volume measurements show important inhibition of primary tumor growth in the mice treated with the U-104 compound compared with vehicle controls |
![]() U-104 |
|||
A4358-25 | ApexBio | 25 mg | EUR 171 |
Description: U-104 is a novel ureido-sulfonamide inhibitor of Carbonic Anhydrase IX (CAIX). Tumor volume measurements show important inhibition of primary tumor growth in the mice treated with the U-104 compound compared with vehicle controls |
![]() U-104 |
|||
A4358-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
Description: U-104 is a novel ureido-sulfonamide inhibitor of Carbonic Anhydrase IX (CAIX). Tumor volume measurements show important inhibition of primary tumor growth in the mice treated with the U-104 compound compared with vehicle controls |
![]() U-104 |
|||
A4358-50 | ApexBio | 50 mg | EUR 270 |
Description: U-104 is a novel ureido-sulfonamide inhibitor of Carbonic Anhydrase IX (CAIX). Tumor volume measurements show important inhibition of primary tumor growth in the mice treated with the U-104 compound compared with vehicle controls |
![]() U-73122 |
|||
B3422-10 | ApexBio | 10 mg | EUR 161 |
Description: U-73122 is an inhibitor of phospholipase C, phospholipase A2, and 5-LO (5-lipoxygenase). |
![]() U-73122 |
|||
B3422-25 | ApexBio | 25 mg | EUR 258 |
Description: U-73122 is an inhibitor of phospholipase C, phospholipase A2, and 5-LO (5-lipoxygenase). |
![]() U-73122 |
|||
B3422-5 | ApexBio | 5 mg | EUR 123 |
Description: U-73122 is an inhibitor of phospholipase C, phospholipase A2, and 5-LO (5-lipoxygenase). |
![]() U-73122 |
|||
B3422-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 166 |
Description: U-73122 is an inhibitor of phospholipase C, phospholipase A2, and 5-LO (5-lipoxygenase). |
![]() U 18666A |
|||
B6812-10 | ApexBio | 10 mg | EUR 150 |
Description: U 18666A is an inhibitor of cholesterol transport and synthesis [1] [2]. Cholesterol is a sterol that biosynthesized by all animal cells and is an essential component of all animal cell membranes that is required to maintain membrane fluidity and structural integrity. |
![]() U 18666A |
|||
B6812-25 | ApexBio | 25 mg | EUR 287 |
Description: U 18666A is an inhibitor of cholesterol transport and synthesis [1] [2]. Cholesterol is a sterol that biosynthesized by all animal cells and is an essential component of all animal cell membranes that is required to maintain membrane fluidity and structural integrity. |
![]() U 18666A |
|||
B6812-50 | ApexBio | 50 mg | EUR 473 |
Description: U 18666A is an inhibitor of cholesterol transport and synthesis [1] [2]. Cholesterol is a sterol that biosynthesized by all animal cells and is an essential component of all animal cell membranes that is required to maintain membrane fluidity and structural integrity. |
![]() U 46619 |
|||
B6890-1 | ApexBio | 1 mg | EUR 147 |
Description: EC50: 0.035 ?M for shape change, 0.057 ?M for MLCP, 0.536 ?M for serotonin release, 1.31 ?M for aggregation. |
![]() U 46619 |
|||
B6890-10 | ApexBio | 10 mg | EUR 830 |
Description: EC50: 0.035 ?M for shape change, 0.057 ?M for MLCP, 0.536 ?M for serotonin release, 1.31 ?M for aggregation. |
![]() U 46619 |
|||
B6890-5 | ApexBio | 5 mg | EUR 487 |
Description: EC50: 0.035 ?M for shape change, 0.057 ?M for MLCP, 0.536 ?M for serotonin release, 1.31 ?M for aggregation. |
![]() EC MEDIUM |
|||
E05-100-10kg | Alphabiosciences | 10 kg | EUR 814 |
![]() EC MEDIUM |
|||
E05-100-2Kg | Alphabiosciences | 2 Kg | EUR 216 |
![]() EC MEDIUM |
|||
E05-100-500g | Alphabiosciences | 500 g | EUR 95 |
![]() COLIFORM MEDIUM |
|||
C03-127-10kg | Alphabiosciences | 10 kg | EUR 1324 |
![]() COLIFORM MEDIUM |
|||
C03-127-2kg | Alphabiosciences | 2kg | EUR 327 |
![]() COLIFORM MEDIUM |
|||
C03-127-500g | Alphabiosciences | 500 g | EUR 125 |
![]() HLP MEDIUM |
|||
H08-107-10kg | Alphabiosciences | 10 kg | EUR 2278 |
![]() HLP MEDIUM |
|||
H08-107-2Kg | Alphabiosciences | 2 Kg | EUR 534 |
![]() HLP MEDIUM |
|||
H08-107-500g | Alphabiosciences | 500 g | EUR 182 |
![]() VALI Medium |
|||
450 | AthenaES | 500 ml | EUR 265 |
![]() DC MEDIUM |
|||
D04-117-10kg | Alphabiosciences | 10 kg | EUR 1579 |
![]() DC MEDIUM |
|||
D04-117-2kg | Alphabiosciences | 2kg | EUR 382 |
![]() DC MEDIUM |
|||
D04-117-500g | Alphabiosciences | 500 g | EUR 140 |
![]() SIM MEDIUM |
|||
S19-110-10kg | Alphabiosciences | 10 kg | EUR 1021 |
![]() SIM MEDIUM |
|||
S19-110-2kg | Alphabiosciences | 2kg | EUR 261 |
![]() SIM MEDIUM |
|||
S19-110-500g | Alphabiosciences | 500 g | EUR 107 |
![]() SOB MEDIUM |
|||
S19-124-10kg | Alphabiosciences | 10 kg | EUR 965 |
![]() SOB MEDIUM |
|||
S19-124-2kg | Alphabiosciences | 2kg | EUR 249 |
![]() SOB MEDIUM |
|||
S19-124-500g | Alphabiosciences | 500 g | EUR 104 |
![]() Advanced Medium |
|||
C0003-04 | Addexbio | RT 500 mL Bottle | EUR 103 |
![]() Medium 199 |
|||
C0012-01 | Addexbio | RT 500 mL Bottle | EUR 105 |
![]() NeuroProgenitor Medium |
|||
NM42400 | Neuromics | 125 ml | EUR 304 |
Coronavirus sygdom 2019 strategier, undersøgelsesdetaljer og sikkerhedsprocedurer for diagnostiske radiologifaciliteter: En omfattende multicenter-oplevelse i Istanbul, Tyrkiet
This research aimed to share our experiences through the coronavirus illness 2019 (COVID-19) pandemic obtained in diagnostic radiology amenities of 5 Coaching Analysis Hospitals within the Asian a part of Istanbul (North Hospitals). Accordingly, we reported the utilised examination particulars, allocation of radiology workers and actions and security procedures for sufferers and radiology workers.
As the company radiology group serving in these designated pandemic hospitals, examination particulars and security procedures of some diagnostic radiology amenities amongst 5 coaching analysis hospitals have been recognized within the present research.
Our pointers and preparedness protocol aimed to scale back affected person morbidity and infection-related mortality by fast and correct analysis to stop the unfold of COVID-19 to our staff, sufferers and most people through the COVID-19 pandemic.
Outcomes confirmed that teamwork is a key issue whereas offering medical companies. As well as, steady communication efforts and particular person obligations of radiology workers had been outstanding through the COVID-19 pandemic.
The current scenario additionally confirmed that co-operation of radiology amenities with system producers and applicators are fairly important particularly for improvement of particular protocols within the body of As Low As Fairly Achievable.
The COVID-19 pandemic has tackled a number of challenges in radiology amongst radiology departments. Due to this fact, steady co-operation plans and motivational actions are extremely really useful not solely between radiology workers but additionally between radiology stakeholders and repair suppliers sooner or later.
Technical particulars of current investigation can present helpful details about the administration of diagnostic radiology departments through the combat with the COVID-19 pandemic in cities with excessive inhabitants density resembling Istanbul.
![]() EverBrite Hardset Mounting Medium |
|||
23003 | Biotium | 10mL | EUR 195 |
Description: Minimum order quantity: 1 unit of 10mL |
![]() EverBrite Mounting Medium with DAPI |
|||
23002 | Biotium | 10mL | EUR 195 |
Description: Minimum order quantity: 1 unit of 10mL |
![]() FluoreGuard Mounting Medium (Hard Set) |
|||
FMH030 | ScyTek Laboratories | 30 ml | EUR 96 |
![]() FluoreGuard Mounting Medium (Hard Set) |
|||
FMH060 | ScyTek Laboratories | 60 ml | EUR 116 |
![]() FluoreGuard Mounting Medium (Hard Set) |
|||
FMH500 | ScyTek Laboratories | 500 ml | EUR 327 |
![]() FluoreGuard Mounting Medium (Hard Set) |
|||
FMH999 | ScyTek Laboratories | 1000 ml | EUR 530 |
![]() Advantage Mounting Media, for permanent mounting and Coverslipping IHC & special stains from water, 60ml |
|||
NB300 | Innovex | 60 ml | EUR 427 |
![]() Advantage Mounting Media, for permanent mounting and Coverslipping IHC & special stains from water, 30ml |
|||
NB300-30 | Innovex | 30 ml | EUR 276 |
![]() Advantage Mounting Media, for permanent mounting and Coverslipping IHC & special stains from water, 125ml |
|||
NB300A | Innovex | 125 ml | EUR 543 |
![]() FluoroQuest™ Mounting Medium with DAPI |
|||
20004 | AAT Bioquest | 50 mL | EUR 132 |
![]() Anti-Fade Mounting Medium (With DAPI) |
|||
abx090690-10ml | Abbexa | 10 ml | EUR 203 |
![]() Anti-Fade Mounting Medium (With PI) |
|||
abx090691-10ml | Abbexa | 10 ml | EUR 203 |
![]() EverBrite Hardset Mounting Medium with DAPI |
|||
23004 | Biotium | 10mL | EUR 213 |
Description: Minimum order quantity: 1 unit of 10mL |
![]() Mounting Media |
|||
99-MED | Fitzgerald | 3 ml | EUR 211 |
Description: Mounting media for use in microscopy preparations |
![]() FluorLast? Mounting Media |
|||
1213-20 | Biovision | EUR 142 |
![]() Buffered Glycerol Mounting Media |
|||
GMM003 | ScyTek Laboratories | 3 ml | EUR 61 |
![]() Buffered Glycerol Mounting Media |
|||
GMM030 | ScyTek Laboratories | 30 ml | EUR 72 |
![]() Buffered Glycerol Mounting Media |
|||
GMM500 | ScyTek Laboratories | 500 ml | EUR 183 |
![]() Buffered Glycerol Mounting Media |
|||
GMM999 | ScyTek Laboratories | 1000 ml | EUR 260 |
![]() Permanent Mounting Media (Aqueous) |
|||
PMT030 | ScyTek Laboratories | 30 ml | EUR 109 |
![]() Permanent Mounting Media (Aqueous) |
|||
PMT999 | ScyTek Laboratories | 1000 ml | EUR 759 |
![]() ReadiUse™ microscope mounting solution |
|||
20009 | AAT Bioquest | 50 mL | EUR 115 |
![]() PolyMount Mounting Media MaxTag Histo (OKRA00045) |
|||
OKRA00045 | Aviva Systems Biology | 15 ml | EUR 126 |
Description: Description of target: ;Species reactivity: ;Application: ;Assay info: ;Sensitivity: |
![]() EC MEDIUM |
|||
E05-100-10kg | Alphabiosciences | 10 kg | EUR 814 |
![]() EC MEDIUM |
|||
E05-100-2Kg | Alphabiosciences | 2 Kg | EUR 216 |
![]() EC MEDIUM |
|||
E05-100-500g | Alphabiosciences | 500 g | EUR 95 |
![]() COLIFORM MEDIUM |
|||
C03-127-10kg | Alphabiosciences | 10 kg | EUR 1324 |
![]() COLIFORM MEDIUM |
|||
C03-127-2kg | Alphabiosciences | 2kg | EUR 327 |
![]() COLIFORM MEDIUM |
|||
C03-127-500g | Alphabiosciences | 500 g | EUR 125 |
![]() HLP MEDIUM |
|||
H08-107-10kg | Alphabiosciences | 10 kg | EUR 2278 |
![]() HLP MEDIUM |
|||
H08-107-2Kg | Alphabiosciences | 2 Kg | EUR 534 |
![]() HLP MEDIUM |
|||
H08-107-500g | Alphabiosciences | 500 g | EUR 182 |
![]() VALI Medium |
|||
450 | AthenaES | 500 ml | EUR 265 |
![]() DC MEDIUM |
|||
D04-117-10kg | Alphabiosciences | 10 kg | EUR 1579 |
![]() DC MEDIUM |
|||
D04-117-2kg | Alphabiosciences | 2kg | EUR 382 |
![]() DC MEDIUM |
|||
D04-117-500g | Alphabiosciences | 500 g | EUR 140 |
![]() SIM MEDIUM |
|||
S19-110-10kg | Alphabiosciences | 10 kg | EUR 1021 |
![]() SIM MEDIUM |
|||
S19-110-2kg | Alphabiosciences | 2kg | EUR 261 |
![]() SIM MEDIUM |
|||
S19-110-500g | Alphabiosciences | 500 g | EUR 107 |
![]() SOB MEDIUM |
|||
S19-124-10kg | Alphabiosciences | 10 kg | EUR 965 |
![]() SOB MEDIUM |
|||
S19-124-2kg | Alphabiosciences | 2kg | EUR 249 |
![]() SOB MEDIUM |
|||
S19-124-500g | Alphabiosciences | 500 g | EUR 104 |
![]() A Medium |
|||
DJ1018 | Bio Basic | 100g | EUR 84.8 |
![]() Advanced Medium |
|||
C0003-04 | Addexbio | RT 500 mL Bottle | EUR 103 |
![]() Medium 199 |
|||
C0012-01 | Addexbio | RT 500 mL Bottle | EUR 105 |
![]() Heller's Medium |
|||
CP014-010 | GenDepot | 10X1L | EUR 99 |
![]() Heller's Medium |
|||
CP014-500 | GenDepot | 50L | EUR 126 |
![]() Hoagland's Medium |
|||
CP015-010 | GenDepot | 10X1L | EUR 99 |
![]() Hoagland's Medium |
|||
CP015-500 | GenDepot | 50L | EUR 126 |
![]() M9 Medium |
|||
SD7024 | Bio Basic | 250g | EUR 71.75 |
![]() M9CA Medium |
|||
SD7025 | Bio Basic | 250g | EUR 71.75 |
![]() YM Medium |
|||
SD7031 | Bio Basic | 250g | EUR 70.45 |
![]() TYGPN Medium |
|||
SD7032 | Bio Basic | 250g | EUR 70.01 |
![]() M63 Medium |
|||
SD7033 | Bio Basic | 250g | EUR 71.75 |
![]() NeuroProgenitor Medium |
|||
NM42400 | Neuromics | 125 ml | EUR 304 |
![]() Fine natural hair brush for mounting sections |
|||
PO501 | FD Neurotechnologies | each | EUR 67 |
![]() Insect Cell Medium: TNM-FH Insect Culture Medium |
|||
ABP-MED-10001 | Allele Biotech | 1 liter | Ask for price |
![]() Insect Cell Medium: Serum-Free Insect Culture Medium |
|||
ABP-MED-10002 | Allele Biotech | 1 liter | Ask for price |
![]() Insect Cell Medium: Grace?s Insect Medium (Unsupplemented) |
|||
ABP-MED-10004 | Allele Biotech | 1 liter | Ask for price |
![]() EC MEDIUM, MODIFIED |
|||
E05-108-10kg | Alphabiosciences | 10 kg | EUR 858 |
![]() EC MEDIUM, MODIFIED |
|||
E05-108-2Kg | Alphabiosciences | 2 Kg | EUR 226 |
![]() EC MEDIUM, MODIFIED |
|||
E05-108-500g | Alphabiosciences | 500 g | EUR 98 |
![]() A-1 MEDIUM |
|||
A01-116-10kg | Alphabiosciences | 10 kg | EUR 1034 |
![]() A-1 MEDIUM |
|||
A01-116-2Kg | Alphabiosciences | 2 Kg | EUR 264 |
![]() A-1 MEDIUM |
|||
A01-116-500g | Alphabiosciences | 500 g | EUR 108 |
![]() CARY & BLAIR MEDIUM |
|||
C03-131-10kg | Alphabiosciences | 10 kg | EUR 2185 |
![]() CARY & BLAIR MEDIUM |
|||
C03-131-2Kg | Alphabiosciences | 2 Kg | EUR 514 |
![]() CARY & BLAIR MEDIUM |
|||
C03-131-500g | Alphabiosciences | 500 g | EUR 176 |
![]() FLUID THIOGLYCOLLATE MEDIUM |
|||
F06-101-10kg | Alphabiosciences | 10 kg | EUR 792 |
![]() FLUID THIOGLYCOLLATE MEDIUM |
|||
F06-101-2kg | Alphabiosciences | 2kg | EUR 211 |
![]() FLUID THIOGLYCOLLATE MEDIUM |
|||
F06-101-500g | Alphabiosciences | 500 g | EUR 94 |
![]() TERRIFIC BROTH MEDIUM |
|||
T20-114-10kg | Alphabiosciences | 10 kg | EUR 675 |
![]() TERRIFIC BROTH MEDIUM |
|||
T20-114-2kg | Alphabiosciences | 2kg | EUR 186 |
![]() TERRIFIC BROTH MEDIUM |
|||
T20-114-500g | Alphabiosciences | 500 g | EUR 87 |
![]() THIOGLYCOLLATE MEDIUM, BREWER |
|||
T20-118-10kg | Alphabiosciences | 10 kg | EUR 1364 |
![]() THIOGLYCOLLATE MEDIUM, BREWER |
|||
T20-118-2kg | Alphabiosciences | 2kg | EUR 336 |
![]() THIOGLYCOLLATE MEDIUM, BREWER |
|||
T20-118-500g | Alphabiosciences | 500 g | EUR 128 |
![]() 2XYT MICROBIAL MEDIUM |
|||
X24-102-10kg | Alphabiosciences | 10 kg | EUR 614 |
![]() 2XYT MICROBIAL MEDIUM |
|||
X24-102-2Kg | Alphabiosciences | 2 Kg | EUR 173 |
![]() 2XYT MICROBIAL MEDIUM |
|||
X24-102-500g | Alphabiosciences | 500 g | EUR 83 |
![]() OF BASAL MEDIUM |
|||
O15-100-10kg | Alphabiosciences | 10 kg | Ask for price |
![]() OF BASAL MEDIUM |
|||
O15-100-2kg | Alphabiosciences | 2kg | Ask for price |
![]() OF BASAL MEDIUM |
|||
O15-100-500g | Alphabiosciences | 500 g | Ask for price |
![]() MOTILITY TEST MEDIUM |
|||
M13-121-10kg | Alphabiosciences | 10 kg | EUR 1528 |
![]() MOTILITY TEST MEDIUM |
|||
M13-121-2Kg | Alphabiosciences | 2 Kg | EUR 371 |
![]() MOTILITY TEST MEDIUM |
|||
M13-121-500g | Alphabiosciences | 500 g | EUR 137 |
![]() REINFORCED CLOSTRIDIUM MEDIUM |
|||
R18-105-10kg | Alphabiosciences | 10 kg | EUR 1194 |
![]() REINFORCED CLOSTRIDIUM MEDIUM |
|||
R18-105-2kg | Alphabiosciences | 2kg | EUR 299 |
![]() REINFORCED CLOSTRIDIUM MEDIUM |
|||
R18-105-500g | Alphabiosciences | 500 g | EUR 118 |
![]() Sepadextran-25 Medium |
|||
SD25M-100 | ABTBeads | 100 g | EUR 271 |
![]() Sepadextran-25 Medium |
|||
SD25M-500 | ABTBeads | 500 g | EUR 1036 |
![]() Sepadextran-50 Medium |
|||
SD50M-100 | ABTBeads | 100 g | EUR 344 |
![]() Sepadextran-50 Medium |
|||
SD50M-500 | ABTBeads | 500 g | EUR 1285 |